SCHEMBL13508007

SCHEMBL13508007

c1ccc2cc(-c3c4ccccc4c(-c4ccc5c(c4)oc4c6oc7cc(-c8c9ccccc9c(-c9ccc%10ccccc%10c9)c9ccccc89)ccc7c6c6ccccc6c54)c4ccccc34)ccc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 2/20 0.43
▸ CYP1B1 Q16678 2/20 0.43
▸ NOTUM Q6P988 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ GPR84 Q9NQS5 1/20 0.36
▸ GSTP1 P09211 1/20 0.35
▸ ESR1 P03372 1/20 0.35
▸ ESR2 Q92731 1/20 0.35
▸ ALOX5 P09917 2/20 0.35
▸ CYP1A2 P05177 5/20 0.35
▸ CYP2C9 P11712 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ HCRTR1 O43613 1/20 0.35
▸ NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24582133 0.97 CYP1A1 (0.42) CYP1A1CYP1B1NOTUMTDP1L3MBTL1
SCHEMBL13508011 0.96 CYP1A1 (0.41) CYP1A1CYP1B1NOTUMTDP1L3MBTL1
SCHEMBL13508220 0.96 CYP1A1 (0.41) CYP1A1CYP1B1NOTUMTDP1L3MBTL1
SCHEMBL16067699 0.94 CYP1A1 (0.42) CYP1A1CYP1B1NOTUMTDP1L3MBTL1
SCHEMBL13508032 0.92 CYP1A1 (0.47) CYP1A1CYP1B1NOTUMTDP1L3MBTL1
SCHEMBL13507835 0.91 CYP1A1 (0.46) CYP1A1CYP1B1NOTUMTDP1L3MBTL1
SCHEMBL17943904 0.90 CYP1A1 (0.39) CYP1A1CYP1B1NOTUMTDP1L3MBTL1
SCHEMBL17246956 0.90 CYP1A1 (0.39) CYP1A1CYP1B1NOTUMTDP1L3MBTL1
SCHEMBL13507104 0.89 CYP1A1 (0.41) CYP1A1CYP1B1NOTUMTDP1L3MBTL1
SCHEMBL16068065 0.89 CYP1A1 (0.39) CYP1A1CYP1B1NOTUMGPR84ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 CYP1A1 776/4885CYP1B1 739/4885NOTUM 202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback